Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Portfolio Pulse from
Candel Therapeutics has closed its public offering, selling 12,000,001 shares of common stock at $6.00 per share, including the full exercise of the underwriters' option for additional shares.
December 16, 2024 | 9:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Candel Therapeutics completed its public offering, selling 12,000,001 shares at $6.00 each, including the full exercise of the underwriters' option for additional shares.
The successful closing of the public offering and full exercise of the underwriters' option indicates strong demand and confidence in Candel Therapeutics' stock, likely leading to a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100